DIABETES TYPE 2 AND OBESITY

Nikolay Kostadinov

doi:10.35120/medisij030231k

Authors

Nikolay Kostadinov University Prof. Dr. Asen Zlatarov-Burgas, Bulgaria

DOI:

https://doi.org/10.35120/medisij030231k

Keywords:

diabetes mellitus type 2, obesity, frequency

Abstract

Diabetes mellitus type 2 is a socially significant disease, which etiologically and pathogenetically is to the greatest extent influenced by body weight. Obesity has become a pandemic of our time. It is most often caused by the imbalance between energy intake and energy expenditure. Excess calories accumulate as fat. In patients with DM type 2, obesity further increases the risk of atherosclerosis, ischemic heart disease, cerebrovascular disease, arterial hypertension, hepatic steatosis, chronic kidney disease, increased mortality. The aim of the present analysis is to determine the frequency of patients with type 2 DM 170 patients with DM type-2 were studied. Of them, 77 with a relative share of 45.% are men, 93 are women, who make up 54.7%. The method of calculating the body mass index, which serves to assess the physical condition of the patients, was applied. After processing the data, it was found that 4.4% of the patients had a normal body weight, 26.5% were overweight, 1st degree obesity - 34.7%, 2nd degree obesity - 20.3% and with obesity of the 3rd degree are 14.1% of the studied patients. Obesity is a serious metabolic disorder that harbors multiple health risk factors that may reduce quality and life expectancy among patients with type-2 DM.

Downloads

Download data is not yet available.

References

Atlanta (2022).Centers for Disease Control and Prevention. Heart disease: prevent heart disease. 2020..: Centers for Disease Control and Prevention. Accessed 9 Jun

Borisova, A.M. (2019). Recommendations for good clinical practice in obesity -BDE

Boye KS, Lage MJ, Terrell K.(2020). Healthcare outcomes for patients with type 2 diabetes with and without comorbid obesity.J Diabetes Complications. 34(12): 107730.

Cohen, R.V., Pereira, T.V. , Aboud, C.M. , Petry, T.B.Z. , Lopes Correa, J.L. , Schiavon, C.E., Pompílio, C.A., Pechy, F.N.Q., da Costa Silva, A.C.C. , de Melo, F.L.G. , et al.(2020)Effect of gastric bypass vs best medical treatment on early-stage chronic kidney disease in patients with type 2 diabetes and obesity: a randomized clinical trial

Dimitrakov,D. (2006).Clinic and therapy of internal diseases

De Lorenzo, A.; Soldati, L.; Sarlo, F.; Calvani, M.; Di Lorenzo, N.; Di Renzo, L. (2016). New obesity classification criteria as a tool for bariatric surgery indication. World J. Gastroenterol. 681–703.

D’Adamo, E.; Caprio, S.(2011) Type 2 diabetes in youth: Epidemiology and pathophysiology. Diabetes Care, 34 (Suppl. S2), S161–S165.

Field, A.E.; Coakley, E.H.; Must, A.; Spadano, J.L.; Laird, N.; Dietz, W.H.; Rimm, E.; Colditz, G.A.(2001). Impact of overweight on the risk of developing common chronic diseases during a 10-year period. Arch. Intern. Med. 161, 1581–1586.

Goyal, R.; Singhal, M.; Jialal, I. (2023).Type 2 diabetes. In StatPearls [Internet]; StatPearls Publishing: Treasure Island, FL, USA

Leitner, D.R.; Frühbeck, G.; Yumuk, V.; Schindler, K.; Micic, D.(2017). Woodward, E.; Toplak, H. Obesity and type 2 diabetes: Two diseases with a need for combined treatment strategies—EASO can lead the way. Obes. Facts, 10, 483–492.

Powers MA,Bardsley JK, Cypress M, and all. (2020). Diabetes self-management education and support in adults with type 2 diabetes. Diabetes Care Jul43(7):1636-1649

Røder, M.E.; Porte, D., Jr.; Schwartz, R.S.; Kahn, S.E.(1998). Disproportionately elevated proinsulin levels reflect the degree of impaired B cell secretory capacity in patients with noninsulin-dependent diabetes mellitus. J. Clin. Endocrinol. Metab. 83, 604–608.

Santomauro, A.T.; Boden, G.; Silva, M.E.; Rocha, D.M.; Santos, R.F.(1999). Ursich, M.J.; Strassmann, P.G.; Wajchenberg, B.L. Overnight lowering of free fatty acids with Acipimox improves insulin resistance and glucose tolerance in obese diabetic and nondiabetic subjects. Diabetes 48, 1836–1841.

Wilding, J.P.(2014). The importance of weight management in type 2 diabetes mellitus. Int. J. Clin. Pract., 68, 682–691.

Wing, R.R.; Lang, W.; Wadden, T.A.; Safford, M.; Knowler, W.C.; Bertoni, A.G.; Hill, J.O.; Brancati, F.L.; Peters, A.(2011). Wagenknecht, L. Benefits of modest weight loss in improving cardiovascular risk factors in overweight and obese individuals with type 2 diabetes. Diabetes Care, 34, 1481–1486.